Atosiban Versus Placebo in the Treatment of Late Threatened Pre-term Birth

NCT05693688 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

760

Enrollment

OTHER

Sponsor class

Conditions

Preterm Birth

Interventions

DRUG: Atosiban

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]